title: Effects of pentoxifylline in the prevention of ovarian hyperstimulation syndrome in a rabbit model.
abstract: Tumor necrosis factor alpha (TNF-alpha) and other cytokines have been implicated in the pathogenesis of ovarian hyperstimulation syndrome (OHSS). Pentoxifylline, a methylxanthine derivative, was found to inhibit TNF-alpha synthesis. The aim of this study was to evaluate whether the use of pentoxifylline would prevent the occurrence of OHSS in a rabbit model. Thirteen rabbits were divided into two groups. The first group (n = 6) were given pentoxifylline 15 mg/kg intravenously and the second group (n = 7) were given physiological serum 15 mg/kg before ovulation induction. Ovarian hyperstimulation was induced in rabbits by 200 IU equine chorionic gonadotropin on day 1 and 100 IU human chorionic gonadotropin on day 3. Blood samples were analyzed for TNF-alpha on days 1, 3 and 5. All animals were autopsied on day 6 to evaluate the ovarian weight, ascites formation and histopathological changes. There was no difference between groups regarding weight gain, ascites formation and plasma TNF-alpha levels (p < 0.05). Ovarian weight and number of ovulations were significantly lower in the pentoxifylline group than the control group (p < 0.05). Pentoxifylline did not prevent ascites formation despite the observed decrease in ovarian weight and number of ovulations in OHSS in a rabbit model.
authors.affiliation: Department of Obstetrics and Gynecology, Erciyes University Medical Faculty, Kayseri, Turkey.
authors.forename: I S
authors.initials: IS
authors.lastname: Serin
authors.forename: B
authors.initials: B
authors.lastname: Ozçelik
authors.forename: T
authors.initials: T
authors.lastname: Bekyurek
authors.forename: F
authors.initials: F
authors.lastname: Ozturk
authors.forename: N
authors.initials: N
authors.lastname: Koc
authors.forename: Y
authors.initials: Y
authors.lastname: Sahin
mesh_terms: D000818:Animals; D006063:Chorionic Gonadotropin / Q000008:administration & dosage; D005260:Female; D009929:Organ Size; D016471:Ovarian Hyperstimulation Syndrome / Q000139:chemically induced / Q000188:drug therapy*; D010053:Ovary / Q000033:anatomy & histology; D010062:Ovulation Induction; D010431:Pentoxifylline / Q000627:therapeutic use*; D011817:Rabbits; D014409:Tumor Necrosis Factor-alpha / Q000032:analysis / Q000037:antagonists & inhibitors
chemical_list: D006063:Chorionic Gonadotropin; D014409:Tumor Necrosis Factor-alpha; D010431:Pentoxifylline